Clinical Trial

A Study of VCT220 in Participants With Hypertension and Obesity or Overweight

Study acronym: VICTOR-HTN
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to explore the safety and efficacy of VCT220 for the treatment of hypertension in participants with obesity or overweight.
Trial Details
NCT Number NCT07360275
Lead Sponsor Vincentage Pharma Co., Ltd
Conditions Hypertension
Enrollment 160 participants
Start Date 2026-03-01
Primary Completion 2026-10-20 (estimated)
Study Completion 2026-12-20 (estimated)
Updated on ClinicalTrials.gov 2026-01-22